¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹À¯¹æ¾ÏÇÐȸ 2023 Ãß°èÇмú´ëȸ : 2023-10-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Çѱ¹À¯¹æ¾ÏÇÐȸ 2023 Ãß°èÇмú´ëȸ : 2023-10-14
±³À°ÀÏÀÚ : 2023-10-14
±³À°Àå¼Ò : ±×·£µåÁ¶¼±Á¦ÁÖ º»°ü2Ãþ ±×·£µåº¼·ë, ÇѶóȦ

±³À°ÁÖÁ¦ : 2023 Ãß°èÇмú´ëȸ

ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060  

À̸ÞÀÏ : kbcs@kbcs.or.kr

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 9 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 200,000¿ø  

ºñ°í "Á¤È¸¿ø, ÁØȸ¿ø 150,000¿ø Àü°øÀÇ, °£È£»ç 100,000¿ø ºñȸ¿ø        200,000¿ø"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 09:10~09:35 Personalized endocrine treatments and CDK4/6 inhibitors for high risk ER positive breast  cancer ¾È¼º±Í(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 09:35~10:00 Best therapeutic strategy for HER2 positive breast cancer with high risk of relapse ¼­°æÁø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 10:00~10:25 Integrating immunotherapy and PARP inhibitors into the standard-of-care for triple negative breast cancer ÀÌÁöÀº(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 10:25~10:50 Beginning the journey of HER2-low disease Á¶ÀºÀ±(¼º±Õ°üÀÇ´ë)

ÈÞ½Ä 10¿ù 14ÀÏ 10:50~11:10 BREAK ( )

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 11:10~11:35 Recent trends of breast cancer surgery in Korea_real world practice of breast and axillary management ÃÖÁ¤Àº(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 11:35~12:00 Do all microcalcifications need to be removed with mastectomy for excellent responders? ¹è¼ö¿¬(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 12:00~12:25 Recent updates and ongoing trials of de-escalating local treatment ÀÌÇѺ°(¼­¿ïÀÇ´ë)

½Ä»ç 10¿ù 14ÀÏ ±×·£µåº¼·ë 12:25~14:00 LUNCH ( )

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 14:00~14:25 Newly defined 'pregnancy associated breast cancer' Á¤ÀçÈ£(¿ï»êÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 14:25~14:50 Understanding lobular breast cancer_perhaps more than a gentle ductal carcinoma ±èÁöÇü(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 14:50~15:15 How to better monitor disease recurrence after standard treatment: Is radiology enough? would ctDNA monitoring lead to survival benefit? ±èÁö¼±(¿ï»êÀÇ´ë)

ÈÞ½Ä 10¿ù 14ÀÏ 15:15~15:35 BREAK ( )

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 15:35~16:00 Fertility preservation for young age patients with breast cancer ÀÌ´Ù¿ë(º¸¶ó¸Åº´¿ø)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 16:00~16:25 Optimal timing for prophylactic surgeries ÀÌÁö¿¬(°æºÏÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ±×·£µåº¼·ë 16:25~16:50 Endocrine therapies for women with low bone mineral density Á¤¹Î¼º(ÇѾçÀÇ´ë)

±âŸ 10¿ù 14ÀÏ ÇѶóȦ 09:10~09:20 ÀÓ»ó½ÃÇèÀ§¿øȸ ¼Ò°³ ¹× ÇöȲ À¯Á¾ÇÑ(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 09:20~09:30 Necessity of post-mastectomy radiotherapy in breast cancer patients with excellent response after neoadjuvant chemotherapy : A phase 3, multicenter, randomized controlled study (NEMESIS, KBCSG-26) ¹è¼þÁØ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 09:30~09:40 Male breast cancer (OASIS project) Â÷ġȯ(ÇѾçÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 09:40~09:50 Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS) ¾È¼º±Í(¿¬¼¼ÀÇ´ë)

±âŸ 10¿ù 14ÀÏ ÇѶóȦ 09:50~10:00 µî·Ï»ç¾÷À§¿øȸ ¼Ò°³ ¹× ÇöȲ Á¤¼Ò¿¬(±¹¸³¾Ï¼¾ÅÍ)

±âŸ 10¿ù 14ÀÏ ÇѶóȦ 10:00~10:15 K-CURE °ø°øµ¥ÀÌÅÍ ¼Ò°³ äÈñÁ¤(±¹¸³¾Ï¼¾ÅÍ)

±âŸ 10¿ù 14ÀÏ ÇѶóȦ 10:15~11:30 µî·Ï»ç¾÷À§¿øȸ ¿ì¼ö ¿¬±¸ ¼Ò°³ ±è¿ë¼®(°¡Å縯ÀÇ´ë)

±âŸ 10¿ù 14ÀÏ ÇѶóȦ 10:30~10:50 Panel discussion ¹è¼þÁØ(¿¬¼¼ÀÇ´ë) Â÷ġȯ(ÇѾçÀÇ´ë) ¾È¼º±Í(¿¬¼¼ÀÇ´ë) äÈñÁ¤(±¹¸³¾Ï¼¾ÅÍ) ±è¿ë¼®(°¡Å縯ÀÇ´ë)( )

ÈÞ½Ä 10¿ù 14ÀÏ 10:50~11:10 BREAK ( )

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 11:10~11:25 Çѱ¹ÀÇ À¯¹æ¾Ï ÀÎ½Ä Çâ»ó Ä·ÆäÀÎÀÇ °ú°Å¿Í ÇöÀç ³ëµ¿¿µ(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 11:25~11:40 ÇÎÅ©¸®º» Ä·ÆäÀÎÀº Áö¼ÓµÇ¾î¾ß Çϴ°¡ ±è±æ¿ø(¿¬ÇÕ´º½º)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 11:40~11:55 Çѱ¹ À¯¹æ¾Ï ÀÎ½Ä Çâ»ó Ä·ÆäÀÎÀÇ ¹Ì·¡ ½ÅÇõÀç(ÇѾçÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 11:55~12:10 Advocacy beyond awareness: driving policy change and research funding À̹ÎÇõ(¼øõÇâÀÇ´ë)

Åä·Ð 10¿ù 14ÀÏ ÇѶóȦ 12:10~12:25 Panel discussion À̹ÎÇõ(¼øõÇâÀÇ´ë) ½ÅÇõÀç(ÇѾçÀÇ´ë) ±è±æ¿ø(¿¬ÇÕ´º½º) ¹ÎÅ¿ø(±¹¹ÎÀϺ¸) ÀÌÁøÇÑ(µ¿¾ÆÀϺ¸)( )

½Ä»ç 10¿ù 14ÀÏ 12:25~14:00 LUNCH ( )

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 14:00~14:15 À¯¹æ¾Ï ÀûÁ¤¼ºÆò°¡ ¹× ÇâÈÄ°úÁ¦ ±è³²·É(°Ç°­º¸Çè½É»çÆò°¡¿ø)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 14:15~14:30 À¯¹æ¾Ï ³»¿ë ¼Ò°³¿Í ÇöȲ °û¹ü¼®(µ¿±¹ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 14:30~14:40 ÇöÀå¿¡¼­ÀÇ °æÇè°ú À̽´ (1) ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 14:40~14:50 ÇöÀå¿¡¼­ÀÇ °æÇè°ú À̽´ (2) ±è±¸»ó(°í½ÅÀÇ´ë)

Åä·Ð 10¿ù 14ÀÏ ÇѶóȦ 14:50~15:15 Panel discussion °û¹ü¼®(µ¿±¹ÀÇ´ë) ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë) ±è±¸»ó(°í½ÅÀÇ´ë) À±ÇöÁ¶(ÀüºÏÀÇ´ë)( )

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 15:35~16:00 Interactive communication in the era of digital healthcare ÀÌÁ¾¿ø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 16:00~16:25 ÃÊÀ½ÆÄÀ̹ÌÁö ±â¹Ý ÀΰøÀ¯¹æº¸Çü¹° Áø´Ü ÀΰøÁö´É ÇÁ·Î±×·¥ °³¹ß ±èÀçÈ«(´õ´õºíÀ¯ÀÇ¿ø)

±³À°½Ã°£ 10¿ù 14ÀÏ ÇѶóȦ 16:25~16:50 ChatGPT:  ¿¬±¸ ¹× Áø·á¿¡ÀÇ È°¿ë¹æ¾È ±ÇÇö¿í(¿ï»êÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹À¯¹æ¾ÏÇÐȸ 2023 Ãß°èÇмú´ëȸ : 2023-10-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѽÅÀåÇÐȸ ÀüÇØÁú°íÇ÷¾Ð¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2023-10-14
´ÙÀ½±Û 2023 ¼ºÀα޼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ Ãß°è ½ÉÆ÷Áö¾ö : 2023-10-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20820 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦31ȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­Á : 2024-06-16 0 6 2024-05-27
20819 ºÎ»ê ´ëÇÑÀ̽ÄÇÐȸ 2024³â ½ÅÀåÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-16 0 7 2024-05-27
20818 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-16 0 13 2024-05-27
20817 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ¾ð¾î°Ë»ç ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-06-16 0 7 2024-05-27
20816 ¼­¿ï Á¦28ȸ ¼­¿ï½Ã³»°úÀÇ»çȸ Á¤±âÃÑȸ ¹× Çмú´ëȸ : 2024-06-16 0 27 2024-05-27
20815 ¼­¿ï 2024³â Á¦16ȸ °æÈñ´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-16 0 24 2024-05-27
20814 ºÎ»ê 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿µ³²¼Ò¾Æ¾Ë·¹¸£±â ½ÉÆ÷Áö¿ò : 2024-06-16 0 12 2024-05-27
20813 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦23Â÷ ½Å»ý¾Æ¼Ò»ý¼ú workshop : 2024-06-16 0 24 2024-05-27
20812 ¼­¿ï 2024³â ´ëÇÑÀÇÇÐÀ¯ÀüÇÐȸ ÀÇÇÐÀ¯ÀüÇÐ Primer Course : 2024-06-16 0 40 2024-05-27
20811 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 43 2024-05-27
20810 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú ÄÄÇ»Åͼö¼úÇÐȸ - Á¦3ȸ ±¹Á¦ ·Îº¿¼ö¼ú ½ÉÆ÷Áö¾ö : 2024-06-15 0 7 2024-05-27
20809 °æ±â ´ëÇѺñ¸¸ÇÐȸ Á¦18ȸ ODOT (One Day Course of Obesity Treatment) : 2024-06-15 0 8 2024-05-27
20808 ¼­¿ï 2024³â Á¦ 1ȸ ºñ¸¸ ¿¬¼ö°­ÁÂ(ObesityCare Pro) : 2024-06-15 0 6 2024-05-27
20807 ¼­¿ï 2024 °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20806 ¼­¿ï ´ëÇѼöºÎ¿Ü°úÇÐȸ ¼öºÎ»óÁö ÇÏ°èÇмú´ëȸ : 2024-06-15 0 6 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷